Abivax S.A. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -354.92%-1,325.33%-3,197.14%-1,415.71%
EBIT Margin -346.12%-1,414.71%-2,756.46%-1,389.54%
EBITDA Margin -346.12%-1,414.71%-2,756.46%-1,389.54%
Operating Margin -346.12%-1,414.71%-2,756.46%-1,389.54%
Net Margin -354.92%-1,325.33%-3,197.14%-1,415.71%
FCF Margin -377.02%-1,183.16%-2,107.66%-1,242.77%
Efficiency
Assets Average 104.44M215.76M285.60M
Equity Average 285.60M
Invested Capital 72.88M52.48M434.79M341.13M
Asset Utilization Ratio 0.050.020.05
Leverage & Solvency
Interest Coverage Ratio -11.63-9.23-4.57-10.18
Debt to Equity 0.240.56
Debt Ratio 0.100.660.240.56
Equity Ratio 1.001.00
Times Interest Earned -11.63-9.23-4.57-10.18
Valuation
Enterprise Value -71.83M-28.40M391.78M298.48M
Market Capitalization 672.74M460.67M
Return Ratios
Return on Sales -3.55%-13.25%-31.97%-14.16%
Return on Capital Employed -1.36%-1.16%-1.00%
Return on Assets -0.61%-0.74%-0.66%
Return on Equity -0.66%